
60.57 Delayed Data As of Jul 06 | ![]() Today’s Change | 37.08 Today|||52-Week Range 180.59 | -48.77% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $4.1B |
Intellia Therapeutics, Inc. 40 Erie Street Cambridge Massachusetts 02139 |
John M. Leonard | President, Chief Executive Officer & Director |
Glenn Goddard | Treasurer, Chief Financial & Accounting Officer |
Laura Sepp-Lorenzino | Chief Scientific Officer & Executive VP |
David Lebwohl | Chief Medical Officer & Executive Vice President |
Eliana Clark | Chief Technology Officer & Executive VP |